Panarese, J. D., Engers, D. W., Wu, Y., Bronson, J. J., Macor, J. E., Chun, A., . . . Lindsley, C. W. (2018). Discovery of VU2957 (Valiglurax): An mGlu(4) Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson’s Disease. ACS Med Chem Lett.
Styl cytowania ChicagoPanarese, Joseph D., et al. "Discovery of VU2957 (Valiglurax): An MGlu(4) Positive Allosteric Modulator Evaluated As a Preclinical Candidate for the Treatment of Parkinson’s Disease." ACS Med Chem Lett 2018.
Styl cytowania MLAPanarese, Joseph D., et al. "Discovery of VU2957 (Valiglurax): An MGlu(4) Positive Allosteric Modulator Evaluated As a Preclinical Candidate for the Treatment of Parkinson’s Disease." ACS Med Chem Lett 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..